# FDA Inspection 1221652 - Richard Bergeron, MD, PhD - October 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/richard-bergeron-md-phd/b05ad8da-3ebf-4eb0-a597-d0d268b08a1b
Source feed: FDA_Inspections

> FDA Inspection 1221652 for Richard Bergeron, MD, PhD on October 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221652
- Company Name: Richard Bergeron, MD, PhD
- Inspection Date: 2023-10-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 547702 - 2008-10-22](https://www.keypedia.com/records/fda_inspections/richard-bergeron-md-phd/f81bfd5f-6de7-4b65-9389-013a22ab9de0)

Company: https://www.keypedia.com/companies/richard-bergeron-md-phd/24eb6fa3-1ba7-46f9-b513-4813feeb9a02

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c